XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
At The Market Offering
Common Stock
Common Stock
At The Market Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
Accumulated Other Comprehensive Income
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ 462,339   $ 8   $ 1,586,616   $ 296 $ (1,124,581)
Beginning balance (in shares) at Dec. 31, 2020     83,372,000          
Issuance of common stock, net of commissions and offering costs, value 1,749 $ 2,382     1,749 $ 2,382    
Issuance of common stock, net of commissions and offering costs, shares       146,000        
RSU settlements, net of shares withheld (1,231)       (1,231)      
RSU settlements, net of shares withheld, shares     449,000          
Issuance of common stock pursuant to employee stock awards, shares     108,000          
Stock-based compensation expense 12,268       12,268      
Net income (loss) (78,335)             (78,335)
Unrealized gain (loss) on available-for-sale securities (135)           (135)  
Ending balance at Mar. 31, 2021 399,037   $ 8   1,601,784   161 (1,202,916)
Ending balance (in shares) at Mar. 31, 2021     84,075,000          
Beginning balance at Dec. 31, 2020 462,339   $ 8   1,586,616   296 (1,124,581)
Beginning balance (in shares) at Dec. 31, 2020     83,372,000          
Net income (loss) (246,792)              
Unrealized gain (loss) on available-for-sale securities (272)              
Ending balance at Sep. 30, 2021 310,141   $ 9   1,681,481   24 (1,371,373)
Ending balance (in shares) at Sep. 30, 2021     88,387,000          
Beginning balance at Mar. 31, 2021 399,037   $ 8   1,601,784   161 (1,202,916)
Beginning balance (in shares) at Mar. 31, 2021     84,075,000          
RSU settlements, net of shares withheld (13)       (13)      
RSU settlements, net of shares withheld, shares     423,000          
Issuance of common stock pursuant to employee stock awards 2,599       2,599      
Issuance of common stock pursuant to employee stock awards, shares     256,000          
Stock-based compensation expense 13,807       13,807      
Net income (loss) (83,793)             (83,793)
Unrealized gain (loss) on available-for-sale securities (99)           (99)  
Ending balance at Jun. 30, 2021 331,538   $ 8   1,618,177   62 (1,286,709)
Ending balance (in shares) at Jun. 30, 2021     84,754,000          
Issuance of common stock, net of commissions and offering costs, value 48,701   $ 1   48,700      
Issuance of common stock, net of commissions and offering costs, shares     3,259,000          
RSU settlements, net of shares withheld, shares     306,000          
Issuance of common stock pursuant to employee stock awards 842       842      
Issuance of common stock pursuant to employee stock awards, shares     68,000          
Stock-based compensation expense 13,762       13,762      
Net income (loss) (84,664)             (84,664)
Unrealized gain (loss) on available-for-sale securities (38)           (38)  
Ending balance at Sep. 30, 2021 310,141   $ 9   1,681,481   24 (1,371,373)
Ending balance (in shares) at Sep. 30, 2021     88,387,000          
Beginning balance at Dec. 31, 2021 279,614   $ 9   1,744,695   (368) (1,464,722)
Beginning balance (in shares) at Dec. 31, 2021     91,671,000          
Issuance of common stock, net of commissions and offering costs, value   $ 20,516       $ 20,516    
Issuance of common stock, net of commissions and offering costs, shares       1,320,000        
RSU settlements, net of shares withheld (616)       (616)      
RSU settlements, net of shares withheld, shares     405,000          
Issuance of common stock pursuant to employee stock awards 96       96      
Issuance of common stock pursuant to employee stock awards, shares     10,000          
Stock-based compensation expense 14,335       14,335      
Net income (loss) (88,105)             (88,105)
Unrealized gain (loss) on available-for-sale securities (1,524)           (1,524)  
Ending balance at Mar. 31, 2022 224,316   $ 9   1,779,026   (1,892) (1,552,827)
Ending balance (in shares) at Mar. 31, 2022     93,406,000          
Beginning balance at Dec. 31, 2021 279,614   $ 9   1,744,695   (368) (1,464,722)
Beginning balance (in shares) at Dec. 31, 2021     91,671,000          
Net income (loss) (153,730)              
Unrealized gain (loss) on available-for-sale securities (2,591)              
Ending balance at Sep. 30, 2022 187,113   $ 9   1,808,515   (2,959) (1,618,452)
Ending balance (in shares) at Sep. 30, 2022     94,879,000          
Beginning balance at Mar. 31, 2022 224,316   $ 9   1,779,026   (1,892) (1,552,827)
Beginning balance (in shares) at Mar. 31, 2022     93,406,000          
RSU settlements, net of shares withheld (3)       (3)      
RSU settlements, net of shares withheld, shares     647,000          
Issuance of common stock pursuant to employee stock awards 1,309       1,309      
Issuance of common stock pursuant to employee stock awards, shares     303,000          
Stock-based compensation expense 14,117       14,117      
Net income (loss) 18,466             18,466
Unrealized gain (loss) on available-for-sale securities (726)           (726)  
Ending balance at Jun. 30, 2022 257,479   $ 9   1,794,449   (2,618) (1,534,361)
Ending balance (in shares) at Jun. 30, 2022     94,356,000          
RSU settlements, net of shares withheld (4)       (4)      
RSU settlements, net of shares withheld, shares     517,000          
Issuance of common stock pursuant to employee stock awards 47       47      
Issuance of common stock pursuant to employee stock awards, shares     6,000          
Stock-based compensation expense 14,023       14,023      
Net income (loss) (84,091)             (84,091)
Unrealized gain (loss) on available-for-sale securities (341)           (341)  
Ending balance at Sep. 30, 2022 $ 187,113   $ 9   $ 1,808,515   $ (2,959) $ (1,618,452)
Ending balance (in shares) at Sep. 30, 2022     94,879,000